| Prof Holly Ann Salley, CRNA | |
|
2570 Haymaker Rd, Monroeville, PA 15146-3513 | |
| (412) 578-5323 | |
| (412) 578-4981 |
| Full Name | Prof Holly Ann Salley |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 32 Years |
| Location | 2570 Haymaker Rd, Monroeville, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225003601 | NPI | - | NPPES |
| 001942247 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | RN289683L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Forbes Hospital | Monroeville, PA | Hospital |
| St Clair Hospital | Pittsburgh, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Clair Anesthesiology Associates Inc | 5294627345 | 49 |
| Allegheny Clinic | 5395649586 | 1941 |
News Archive
Genentech, Inc. has announced an update for the previously reported Roche-sponsored international Phase III clinical study (AVAiL) of Avastin (bevacizumab) in combination with gemcitabine and cisplatin chemotherapy, in patients with advanced, non-squamous, non-small cell lung cancer (NSCLC).
Today, the Senior Center for Health and Security (SCHS) announced the publication of an important new white paper which fully explores the critical nature of high-quality physician hospitals for seniors, their promise for the nation, and their competitors' latest effort to drive them completely out of existence.
Scil Proteins, a private biopharmaceutical company specialized in the research, development and production of recombinant proteins, today announced that it has signed an agreement with Anabasis Pharma.
Acute Ischemic Stroke Guidelines are the subject of a new toolkit from the American Heart Association/American Stroke Association aimed at accelerating adoption of the 2015 update regarding endovascular treatment.
› Verified 4 days ago
| Entity Name | University Of Pittsburgh Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619935004 PECOS PAC ID: 8729990239 Enrollment ID: O20040308000883 |
News Archive
Genentech, Inc. has announced an update for the previously reported Roche-sponsored international Phase III clinical study (AVAiL) of Avastin (bevacizumab) in combination with gemcitabine and cisplatin chemotherapy, in patients with advanced, non-squamous, non-small cell lung cancer (NSCLC).
Today, the Senior Center for Health and Security (SCHS) announced the publication of an important new white paper which fully explores the critical nature of high-quality physician hospitals for seniors, their promise for the nation, and their competitors' latest effort to drive them completely out of existence.
Scil Proteins, a private biopharmaceutical company specialized in the research, development and production of recombinant proteins, today announced that it has signed an agreement with Anabasis Pharma.
Acute Ischemic Stroke Guidelines are the subject of a new toolkit from the American Heart Association/American Stroke Association aimed at accelerating adoption of the 2015 update regarding endovascular treatment.
› Verified 4 days ago
| Entity Name | Allegheny Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073081493 PECOS PAC ID: 5395649586 Enrollment ID: O20040310000602 |
News Archive
Genentech, Inc. has announced an update for the previously reported Roche-sponsored international Phase III clinical study (AVAiL) of Avastin (bevacizumab) in combination with gemcitabine and cisplatin chemotherapy, in patients with advanced, non-squamous, non-small cell lung cancer (NSCLC).
Today, the Senior Center for Health and Security (SCHS) announced the publication of an important new white paper which fully explores the critical nature of high-quality physician hospitals for seniors, their promise for the nation, and their competitors' latest effort to drive them completely out of existence.
Scil Proteins, a private biopharmaceutical company specialized in the research, development and production of recombinant proteins, today announced that it has signed an agreement with Anabasis Pharma.
Acute Ischemic Stroke Guidelines are the subject of a new toolkit from the American Heart Association/American Stroke Association aimed at accelerating adoption of the 2015 update regarding endovascular treatment.
› Verified 4 days ago
| Entity Name | St Clair Anesthesiology Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154380384 PECOS PAC ID: 5294627345 Enrollment ID: O20040325000797 |
News Archive
Genentech, Inc. has announced an update for the previously reported Roche-sponsored international Phase III clinical study (AVAiL) of Avastin (bevacizumab) in combination with gemcitabine and cisplatin chemotherapy, in patients with advanced, non-squamous, non-small cell lung cancer (NSCLC).
Today, the Senior Center for Health and Security (SCHS) announced the publication of an important new white paper which fully explores the critical nature of high-quality physician hospitals for seniors, their promise for the nation, and their competitors' latest effort to drive them completely out of existence.
Scil Proteins, a private biopharmaceutical company specialized in the research, development and production of recombinant proteins, today announced that it has signed an agreement with Anabasis Pharma.
Acute Ischemic Stroke Guidelines are the subject of a new toolkit from the American Heart Association/American Stroke Association aimed at accelerating adoption of the 2015 update regarding endovascular treatment.
› Verified 4 days ago
| Entity Name | Premier Anesthesia Services Of Southwestern Pennsylvania Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649574468 PECOS PAC ID: 8426234097 Enrollment ID: O20110516000542 |
News Archive
Genentech, Inc. has announced an update for the previously reported Roche-sponsored international Phase III clinical study (AVAiL) of Avastin (bevacizumab) in combination with gemcitabine and cisplatin chemotherapy, in patients with advanced, non-squamous, non-small cell lung cancer (NSCLC).
Today, the Senior Center for Health and Security (SCHS) announced the publication of an important new white paper which fully explores the critical nature of high-quality physician hospitals for seniors, their promise for the nation, and their competitors' latest effort to drive them completely out of existence.
Scil Proteins, a private biopharmaceutical company specialized in the research, development and production of recombinant proteins, today announced that it has signed an agreement with Anabasis Pharma.
Acute Ischemic Stroke Guidelines are the subject of a new toolkit from the American Heart Association/American Stroke Association aimed at accelerating adoption of the 2015 update regarding endovascular treatment.
› Verified 4 days ago
| Entity Name | Ohio Valley General Hospital |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1790341907 PECOS PAC ID: 8123079613 Enrollment ID: O20190710002607 |
News Archive
Genentech, Inc. has announced an update for the previously reported Roche-sponsored international Phase III clinical study (AVAiL) of Avastin (bevacizumab) in combination with gemcitabine and cisplatin chemotherapy, in patients with advanced, non-squamous, non-small cell lung cancer (NSCLC).
Today, the Senior Center for Health and Security (SCHS) announced the publication of an important new white paper which fully explores the critical nature of high-quality physician hospitals for seniors, their promise for the nation, and their competitors' latest effort to drive them completely out of existence.
Scil Proteins, a private biopharmaceutical company specialized in the research, development and production of recombinant proteins, today announced that it has signed an agreement with Anabasis Pharma.
Acute Ischemic Stroke Guidelines are the subject of a new toolkit from the American Heart Association/American Stroke Association aimed at accelerating adoption of the 2015 update regarding endovascular treatment.
› Verified 4 days ago
| Entity Name | Taormina Anesthesia Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255970653 PECOS PAC ID: 3971939190 Enrollment ID: O20200207000028 |
News Archive
Genentech, Inc. has announced an update for the previously reported Roche-sponsored international Phase III clinical study (AVAiL) of Avastin (bevacizumab) in combination with gemcitabine and cisplatin chemotherapy, in patients with advanced, non-squamous, non-small cell lung cancer (NSCLC).
Today, the Senior Center for Health and Security (SCHS) announced the publication of an important new white paper which fully explores the critical nature of high-quality physician hospitals for seniors, their promise for the nation, and their competitors' latest effort to drive them completely out of existence.
Scil Proteins, a private biopharmaceutical company specialized in the research, development and production of recombinant proteins, today announced that it has signed an agreement with Anabasis Pharma.
Acute Ischemic Stroke Guidelines are the subject of a new toolkit from the American Heart Association/American Stroke Association aimed at accelerating adoption of the 2015 update regarding endovascular treatment.
› Verified 4 days ago
| Entity Name | Valley Medical Facilities, Inc. |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1790341907 PECOS PAC ID: 8325956592 Enrollment ID: O20200729000041 |
News Archive
Genentech, Inc. has announced an update for the previously reported Roche-sponsored international Phase III clinical study (AVAiL) of Avastin (bevacizumab) in combination with gemcitabine and cisplatin chemotherapy, in patients with advanced, non-squamous, non-small cell lung cancer (NSCLC).
Today, the Senior Center for Health and Security (SCHS) announced the publication of an important new white paper which fully explores the critical nature of high-quality physician hospitals for seniors, their promise for the nation, and their competitors' latest effort to drive them completely out of existence.
Scil Proteins, a private biopharmaceutical company specialized in the research, development and production of recombinant proteins, today announced that it has signed an agreement with Anabasis Pharma.
Acute Ischemic Stroke Guidelines are the subject of a new toolkit from the American Heart Association/American Stroke Association aimed at accelerating adoption of the 2015 update regarding endovascular treatment.
› Verified 4 days ago
| Entity Name | Kbs Anesthesia, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801559349 PECOS PAC ID: 1254719321 Enrollment ID: O20220601001484 |
News Archive
Genentech, Inc. has announced an update for the previously reported Roche-sponsored international Phase III clinical study (AVAiL) of Avastin (bevacizumab) in combination with gemcitabine and cisplatin chemotherapy, in patients with advanced, non-squamous, non-small cell lung cancer (NSCLC).
Today, the Senior Center for Health and Security (SCHS) announced the publication of an important new white paper which fully explores the critical nature of high-quality physician hospitals for seniors, their promise for the nation, and their competitors' latest effort to drive them completely out of existence.
Scil Proteins, a private biopharmaceutical company specialized in the research, development and production of recombinant proteins, today announced that it has signed an agreement with Anabasis Pharma.
Acute Ischemic Stroke Guidelines are the subject of a new toolkit from the American Heart Association/American Stroke Association aimed at accelerating adoption of the 2015 update regarding endovascular treatment.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Prof Holly Ann Salley, CRNA 2570 Haymaker Rd, Monroeville, PA 15146-3513 Ph: (412) 578-5323 | Prof Holly Ann Salley, CRNA 2570 Haymaker Rd, Monroeville, PA 15146-3513 Ph: (412) 578-5323 |
News Archive
Genentech, Inc. has announced an update for the previously reported Roche-sponsored international Phase III clinical study (AVAiL) of Avastin (bevacizumab) in combination with gemcitabine and cisplatin chemotherapy, in patients with advanced, non-squamous, non-small cell lung cancer (NSCLC).
Today, the Senior Center for Health and Security (SCHS) announced the publication of an important new white paper which fully explores the critical nature of high-quality physician hospitals for seniors, their promise for the nation, and their competitors' latest effort to drive them completely out of existence.
Scil Proteins, a private biopharmaceutical company specialized in the research, development and production of recombinant proteins, today announced that it has signed an agreement with Anabasis Pharma.
Acute Ischemic Stroke Guidelines are the subject of a new toolkit from the American Heart Association/American Stroke Association aimed at accelerating adoption of the 2015 update regarding endovascular treatment.
› Verified 4 days ago
Jennifer Marie Paul, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2570 Haymaker Rd, Monroeville, PA 15146 Phone: 412-858-2000 | |
Jessica Marie Dube, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2570 Haymaker Rd, Monroeville, PA 15146 Phone: 412-858-4485 | |
Ashley J Brant, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2570 Haymaker Rd, Monroeville, PA 15146 Phone: 412-858-2000 | |
Patrick Dougherty, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2570 Haymaker Rd, Upmc East, Monroeville, PA 15146 Phone: 412-858-2000 | |
Michele Falcon, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2570 Haymaker Rd, Monroeville, PA 15146 Phone: 412-858-4485 Fax: 412-858-3190 | |
Tessa Manolis Meenan, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 2570 Haymaker Rd, Monroeville, PA 15146 Phone: 412-578-5323 Fax: 412-578-4981 | |
Danielle Steeley, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2775 Mosside Blvd, Upmc East, Monroeville, PA 15146 Phone: 412-357-3003 |